Global Human Prothrombin Complex Market Research Report 2023(Status and Outlook)

Global Human Prothrombin Complex Market Research Report 2023(Status and Outlook)



Report Overview

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.

Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.

In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.

The Global Human Prothrombin Complex Market Size was estimated at USD 1419.00 million in 2022 and is projected to reach USD 3097.95 million by 2029, exhibiting a CAGR of 11.80% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Human Prothrombin Complex market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Prothrombin Complex Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Prothrombin Complex market in any manner.

Global Human Prothrombin Complex Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Takeda

CSL

Grifols

Octapharma

Hualan Biological

Meheco Xinxing Pharma

Market Segmentation (by Type)

500 IU/Vial

600 IU/Vial

1000 IU/Vial

Others

Market Segmentation (by Application)

Cancer Treatment

Ophthalmic Use

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Human Prothrombin Complex Market

Overview of the regional outlook of the Human Prothrombin Complex Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Prothrombin Complex
1.2 Key Market Segments
1.2.1 Human Prothrombin Complex Segment by Type
1.2.2 Human Prothrombin Complex Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Human Prothrombin Complex Market Overview
2.1 Global Market Overview
2.1.1 Global Human Prothrombin Complex Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Human Prothrombin Complex Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Human Prothrombin Complex Market Competitive Landscape
3.1 Global Human Prothrombin Complex Sales by Manufacturers (2018-2023)
3.2 Global Human Prothrombin Complex Revenue Market Share by Manufacturers (2018-2023)
3.3 Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Prothrombin Complex Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Human Prothrombin Complex Sales Sites, Area Served, Product Type
3.6 Human Prothrombin Complex Market Competitive Situation and Trends
3.6.1 Human Prothrombin Complex Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Prothrombin Complex Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Human Prothrombin Complex Industry Chain Analysis
4.1 Human Prothrombin Complex Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Prothrombin Complex Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Human Prothrombin Complex Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Prothrombin Complex Sales Market Share by Type (2018-2023)
6.3 Global Human Prothrombin Complex Market Size Market Share by Type (2018-2023)
6.4 Global Human Prothrombin Complex Price by Type (2018-2023)
7 Human Prothrombin Complex Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Prothrombin Complex Market Sales by Application (2018-2023)
7.3 Global Human Prothrombin Complex Market Size (M USD) by Application (2018-2023)
7.4 Global Human Prothrombin Complex Sales Growth Rate by Application (2018-2023)
8 Human Prothrombin Complex Market Segmentation by Region
8.1 Global Human Prothrombin Complex Sales by Region
8.1.1 Global Human Prothrombin Complex Sales by Region
8.1.2 Global Human Prothrombin Complex Sales Market Share by Region
8.2 North America
8.2.1 North America Human Prothrombin Complex Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Prothrombin Complex Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Prothrombin Complex Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Prothrombin Complex Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Prothrombin Complex Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Takeda
9.1.1 Takeda Human Prothrombin Complex Basic Information
9.1.2 Takeda Human Prothrombin Complex Product Overview
9.1.3 Takeda Human Prothrombin Complex Product Market Performance
9.1.4 Takeda Business Overview
9.1.5 Takeda Human Prothrombin Complex SWOT Analysis
9.1.6 Takeda Recent Developments
9.2 CSL
9.2.1 CSL Human Prothrombin Complex Basic Information
9.2.2 CSL Human Prothrombin Complex Product Overview
9.2.3 CSL Human Prothrombin Complex Product Market Performance
9.2.4 CSL Business Overview
9.2.5 CSL Human Prothrombin Complex SWOT Analysis
9.2.6 CSL Recent Developments
9.3 Grifols
9.3.1 Grifols Human Prothrombin Complex Basic Information
9.3.2 Grifols Human Prothrombin Complex Product Overview
9.3.3 Grifols Human Prothrombin Complex Product Market Performance
9.3.4 Grifols Business Overview
9.3.5 Grifols Human Prothrombin Complex SWOT Analysis
9.3.6 Grifols Recent Developments
9.4 Octapharma
9.4.1 Octapharma Human Prothrombin Complex Basic Information
9.4.2 Octapharma Human Prothrombin Complex Product Overview
9.4.3 Octapharma Human Prothrombin Complex Product Market Performance
9.4.4 Octapharma Business Overview
9.4.5 Octapharma Human Prothrombin Complex SWOT Analysis
9.4.6 Octapharma Recent Developments
9.5 Hualan Biological
9.5.1 Hualan Biological Human Prothrombin Complex Basic Information
9.5.2 Hualan Biological Human Prothrombin Complex Product Overview
9.5.3 Hualan Biological Human Prothrombin Complex Product Market Performance
9.5.4 Hualan Biological Business Overview
9.5.5 Hualan Biological Human Prothrombin Complex SWOT Analysis
9.5.6 Hualan Biological Recent Developments
9.6 Meheco Xinxing Pharma
9.6.1 Meheco Xinxing Pharma Human Prothrombin Complex Basic Information
9.6.2 Meheco Xinxing Pharma Human Prothrombin Complex Product Overview
9.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Product Market Performance
9.6.4 Meheco Xinxing Pharma Business Overview
9.6.5 Meheco Xinxing Pharma Recent Developments
10 Human Prothrombin Complex Market Forecast by Region
10.1 Global Human Prothrombin Complex Market Size Forecast
10.2 Global Human Prothrombin Complex Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Prothrombin Complex Market Size Forecast by Country
10.2.3 Asia Pacific Human Prothrombin Complex Market Size Forecast by Region
10.2.4 South America Human Prothrombin Complex Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Prothrombin Complex by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Human Prothrombin Complex Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Human Prothrombin Complex by Type (2024-2029)
11.1.2 Global Human Prothrombin Complex Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Human Prothrombin Complex by Type (2024-2029)
11.2 Global Human Prothrombin Complex Market Forecast by Application (2024-2029)
11.2.1 Global Human Prothrombin Complex Sales (K MT) Forecast by Application
11.2.2 Global Human Prothrombin Complex Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings